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Introduction

Discussion

Amniotic fluid embolism (AFE) is a rare and commonly fatal [13] obstetric emergency theorized to trigger an inflammatory reaction
much like the systemic inflammatory response syndrome (SIRS) of
sepsis [4,5], leading to vascular constriction and coagulation. This
often results in ARDS, cardiac arrest, disseminated intravascular
coagulation (DIC), and death [6]. With such similar theorized
mechanisms, we suspect factors that may modify mortality in
sepsis may also modify mortality in AFE. Specifically, we ask if
alterations in the coagulation cascade of heterozygous Factor V
Leiden mutation (FVL+/-) can decrease mortality in AFE, as seen in
studies with severe sepsis [7,8]. The following case describes the labor
course of a patient with FVL+/- complicated by a postpartum AFE that
did not progress to DIC.

With DIC being one of the criteria set by the Society for Maternal-Fetal
Medicine (SMFM) and Amniotic Fluid Embolism Foundation (Table 1) for
AFE diagnosis, we present an atypical presentation of AFE due to the
absence of DIC. Defined by uncontrolled microvascular thrombosis and
coagulation factor depletion, DIC has been associated with increased
mortality rates in the setting of severe sepsis [9]. As DIC does not always
present with sepsis or AFE, it appears there may be certain mechanisms
that alter the coagulation cascade, and thus, the risk of developing DIC.
One would believe that FVL+/- would lead to increased mortality in the
setting of sepsis. However, the opposite has proven to be true [8]. In FVL+/- ,
Factor V is resistant to cleavage by activated Protein C (APC), leading to
increased thrombin and a hypercoagulable state. It is known that
hypercoagulability activates the thrombomodulin/APC mechanisms [7,10].
These mechanisms increase the anti-inflammatory processes believed to
attenuate DIC, which become severely impaired in sepsis [10] (Figure 3). It
is reasonable to believe that the increased availability of APC along the antiinflammatory pathways explains why our patient did not progress to
overt DIC and ultimately survived this event. Finally, is there a way to utilize
this pathway to improve survival rates in other AFE cases or in severe
sepsis?
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Figure 1: A. Opacity and consolidation of almost the entire left lung. Mild venous
congestion noted. B. Significant improvement of the now mild bilateral airspace disease
the following day,

Table 1: Diagnostic criteria for AFE
1. Sudden onset of cardiorespiratory arrest, or both hypotension
(systolic blood pressure <90 mm Hg) and respiratory compromise
(dyspnea, cyanosis, or peripheral capillary oxygen saturation
[SpO2] <90%)
2. DIC*
3. Clinical onset during labor or within 30 min of delivery of
placenta
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4. No fever (≥38.0°C) during labor
*per Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis (ISTH) scoring
system

Case
Patient is a 31-year-old G2P0 with a history of FVL+/- that presented for
a scheduled induction of labor at 40 weeks and 5 days gestational age.
During her induction, an umbilical cord prolapse required an emergent
cesarean section. She suddenly developed shortness of breath,
confusion, cyanosis, hypotension, bradycardia, and hypoxemia, with a
sharp decline in oxygen saturation, from 92% to 21% approximately 30
minutes after. She lost radial/carotid pulses, CPR was initiated, and she
was intubated. Pulses returned after 3 rounds of chest compressions
and a dose of epinephrine. She was transferred to the ICU where she
was started on Levophed for refractory hypotension. EKG showed sinus
bradycardia. Chest X-ray showed severe airway disease (Figure 1A).
Chest CTA further demonstrated airspace opacities in both lungs (Figure
2). There was no evidence of DVT. Other lab findings showed
hypokalemia, lactic acidosis, normal coagulation panel, and a fibrinogen
level of 399 mg/dL. The patient's condition drastically improved
overnight, and she was successfully extubated the next day. Repeat
chest X-ray showed significant improvement (Figure 1B). Patient was
transferred to mother-baby the following day, started on therapeutic
Lovenox, and discharged home on post-operative day 5.

Figure 2: Multiple CT angiogram views of the chest showing severe airspace opacities of
the left lung and moderately severe airspace opacities of the right lung suggestive of
amniotic fluid embolism. No evidence of right ventricular prominence or strain pattern. A.
Transverse view B. Sagittal view

Conclusion
Whether FVL+/- is an evolutionary advantage given the high prevalence in
the population versus an unfavorable inheritance remains controversial. It
seems the largest protection of FVL+/- lies behind its mechanism to
decrease mortality in severe sepsis and DIC development, protecting
pregnant patients against one of the most fatal complications: Amniotic
Fluid Embolism. Whether this was just an atypical AFE presentation or a
protective effect of FVL+/- is unknown due to the lack of similar published
cases, retrospective or prospective studies. More research is required to
fully understand the role of FVL+/- and APC resistance in the potential
prevention of DIC or sepsis associated coagulopathy.
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